" US Market Launch Will generate Dramtic Shift In Longs Favor " Posted.
A final clearance for take-off in the U.S. market for Arena's Belviq would likely be accompanied by renewed discussion of milestone payments and royalties. Arena is expected to receive $5.0 million from its marketing partner upon receiving a DEA designation and another $60 million upon Belviq's launch. Then royalties begin. Arena's CFO at one point suggested the first $1.0 billion in total sales could trigger royalties in excess of $300 million.
Chatter about payments and cash flows along with the enthusiastic re-calculation of future revenue and
profits are likely to generate a dramatic shift in sentiment, turning up the volume on Arena valuation and stock price. If that happens, it might be ARNA bears who are nibbling on their digits